We had previously detected Sema3A mRNA in active MS lesions [54], but now describe little protein expression, and this discrepancy is not unprecedented within the brain, as PMP22 mRNA is expressed in oligodendrocytes, but no PMP22 protein is present [22]. Here, SEMA3A is linked to myeloid sarcoma.